SNMMI touts JNM's rising impact factor
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is highlighting...Read more on AuntMinnie.comRelated Reading: SNMMI announces new officers for 2018-2019 SNMMI 2018: A year of promotion and ongoing challenges SNMMI schedules training forum for annual meeting SNMMI offers open access option for JNM SNMMI seeks to boost molecular imaging's value (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 19, 2018 Category: Radiology Source Type: news

Support urged for funding for U.S. Mo-99 supply
A consortium of radiology associations, patient advocacy groups, and radiology...Read more on AuntMinnie.comRelated Reading: Australian reactor woes worry nuclear medicine Can nuclear medicine avoid another Mo-99 shortage? FDA, NRC clear path for U.S. supply of molybdenum-99 SNMMI pushes Congress for U.S.-based Mo-99 supply Report warns of shortages to Mo-99 supply in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 19, 2018 Category: Radiology Source Type: news

The Journal of Nuclear Medicine impact factor increases by 12 percent
(Society of Nuclear Medicine and Molecular Imaging) The Journal of Nuclear Medicine (JNM)--the flagship publication of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)--has again been ranked among the top medical imaging journals worldwide, according to new data released in the 2017 Journal Citation Reports © published by Clarivate Analytics. JNM's impact factor went up from 6.646 (2016) to 7.439 (2017). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 18, 2018 Category: International Medicine & Public Health Source Type: news

NTP execs return to work after inquiry
Three senior executives at South African radioisotope firm NTP Radioisotopes...Read more on AuntMinnie.comRelated Reading: Can nuclear medicine avoid another Mo-99 shortage? South African facility resumes Mo-99 production South African Mo-99 maker completes LEU conversion NTP temporarily halts Mo-99 production South African reactor starts moly production (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2018 Category: Radiology Source Type: news

Time-of-flight PET can reduce radiation dose in pediatrics
By adding a time-of-flight technique to pediatric PET scans, clinicians can...Read more on AuntMinnie.comRelated Reading: Study tracks radiation dose to NM technologists Artificial intelligence guides lower PET tracer dose FDA guidance urges lower radiation dose for kids SNMMI: Education eases patients' nuclear medicine fears Radiation exposure monitoring needs a personal touch (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 9, 2018 Category: Radiology Source Type: news

Australian reactor woes worry nuclear medicine
The shutdown of shipments from a nuclear reactor in Australia that is a key...Read more on AuntMinnie.comRelated Reading: Live from SNMMI 2018: Update on radiopharmaceuticals Live from SNMMI 2018: Securing the molybdenum supply Can nuclear medicine avoid another Mo-99 shortage? Canada's NRU reactor to go offline for the final time NorthStar's novel generator could relieve U.S. isotope shortages (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 6, 2018 Category: Radiology Source Type: news

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise
(Society of Nuclear Medicine and Molecular Imaging) In a mouse model, researchers have demonstrated that a novel, affibody-based pretargeted radionuclide therapy for HER2 (human epidermal growth factor receptor 2)-expressing cancers is non-toxic to the kidneys and improves survival. The study is reported in The Journal of Nuclear Medicine's July featured article of the month. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2018 Category: Cancer & Oncology Source Type: news

SNMMI 65th Annual Meeting sets the stage for a revolution in precision medicine
(Society of Nuclear Medicine and Molecular Imaging) More than 5,000 physicians, technologists, scientists and exhibitors gathered for the Society of Nuclear Medicine and Molecular Imaging's 65th Annual Meeting, held June 23-26 in Philadelphia. With nuclear medicine playing a growing role in providing precision medicine, theranostics (combining diagnostic imaging and targeted radionuclide therapy) were an important focus throughout the meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2018 Category: International Medicine & Public Health Source Type: news

Fault at Lucas Heights nuclear reactor halts production of medical isotope
Spokesman says no safety risk but there are fears patients could face delays in cancer diagnosisPatients in hospitals around Australia may face delays in cancer diagnosis after production of the most commonly used isotope in nuclear medicine was halted at the Lucas Heights nuclear reactor in Sydney ’s south.The Australian Nuclear Science and Technology Organisation (Ansto) usually produces about 10,000 doses a week of Technetium-99m (Tc-99m), which is used to diagnose a variety of heart, lung and musculoskeletal conditions, as well as cancers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 28, 2018 Category: Science Authors: Guardian staff Tags: Sydney Nuclear power Australia news Medical research Cancer Science Health Source Type: news

Better Imaging for Prostate Cancer Patients?
The objective [of LOCATE] was to access the impact of positron imaging for patient management,” Peter Gardiner, Blue Earth Diagnostics CMO, told MD+DI. “These were men with recurrent prostate cancer.” For the LOCATE trial 213 men with biochemically recurrent prostate cancer were evaluated with 18F-fluciclovine PET/CT after having negative or equivocal findings on conventional imaging, such as a bone scan, CT or MRI. This first prospective multi-center study was conducted at 15 sites in the U.S., including both private practices and academic settings. It focused on the association between scan positivity a...
Source: MDDI - June 27, 2018 Category: Medical Devices Authors: Omar Ford Tags: Imaging Testing Source Type: news

Live from SNMMI 2018: Update on radiopharmaceuticals
What's going on in the world of medical isotopes? From molybdenum supply to...Read more on AuntMinnie.comRelated Reading: Live from SNMMI 2018: Nuclear medicine and patients Live from SNMMI 2018: Securing the molybdenum supply Live from SNMMI 2018: Nuclear medicine appropriate use Live from SIIM 2018: AI and value-based healthcare Live from SIIM 2018: From pen and ink to AI in radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2018 Category: Radiology Source Type: news

Live from SNMMI 2018: Nuclear medicine and patients
Patients justifiably are the centers of attention in imaging procedures, and...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT Live from SNMMI 2018: Securing the molybdenum supply Live from SNMMI 2018: Nuclear medicine appropriate use SNMMI 2018: A year of promotion and ongoing challenges (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2018 Category: Radiology Source Type: news

New radionucleotide therapy effective to treat neuroendocrine tumours
A new study in humans, presented during the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, shows that a new, long-lasting radionucleotide therapy is effective for the treatment of advanced metastatic NETs.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 26, 2018 Category: Endocrinology Source Type: news

Early treatment of advanced prostate cancer with radioligand therapy prolongs life
(Society of Nuclear Medicine and Molecular Imaging) Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates for the first time the benefit of providing earlier lutetium-177 (177Lu) prostate-specific membrane antigen (PSMA) radioligand therapy to patients with metastatic prostate cancer. Until now, this therapy has only been used in patients with end-stage disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Fluciclovine PET/CT locates recurrent prostate cancer and advises management
(Society of Nuclear Medicine and Molecular Imaging) The addition of fluorine-18 (18F)-fluciclovine positron emission tomography/computed tomography (PET/CT) to the diagnostic work-up of patients with biochemical recurrence of prostate cancer locates previously undetected lesions and changes treatment management for the majority of patients, according to a clinical trial report presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

SNMMI image of the year: PSMA PET imaging of theranostic for advanced prostate cancer
(Society of Nuclear Medicine and Molecular Imaging) Studies of patients with metastatic castrate-resistant prostate cancer have demonstrated high response rates to radionuclide therapy targeting PSMA with the radionuclide lutetium-177. At the SNMMI Annual Meeting, researchers reported on a phase II prospective trial. Men who had exhausted conventional therapies were screened using gallium-68-PSMA11 PET imaging. Those with high PSMA-expression had 177Lu-PSMA617 therapy and experienced high response rates, which is clearly shown in the figure selected as the 2018 SNMMI Image of the Year. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2018 Category: International Medicine & Public Health Source Type: news

Society of Nuclear Medicine and Molecular Imaging announces 2018 Fellows
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging recognized 14 new SNMMI Fellows on June 25 during a Special Plenary Session at the society's 2018 Annual Meeting, held June 23-26 in Philadelphia. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is one of the most prestigious formal recognitions available to long-time SNMMI members. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2018 Category: International Medicine & Public Health Source Type: news

Live from SNMMI 2018: Nuclear medicine appropriate use
What's the best way to promote appropriate use of nuclear medicine? Dr. Sukhjeet...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT SNMMI: New therapy aids patients with neuroendocrine tumors SNMMI: AI can predict survival in sarcoma patients Live from SNMMI 2018: Securing the molybdenum supply SNMMI 2018: A year of promotion and ongoing challenges (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

Live from SNMMI 2018: Securing the molybdenum supply
Global efforts are underway to ensure that adequate supplies of molybdenum-99...Read more on AuntMinnie.comRelated Reading: SNMMI 2018: A year of promotion and ongoing challenges Can nuclear medicine avoid another Mo-99 shortage? Canadians create nuclear isotope council Canada's NRU reactor to go offline for the final time NorthStar's novel generator could relieve U.S. isotope shortages (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

SNMMI announces new officers for 2018-2019
PHILADELPHIA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI)...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT SNMMI: New therapy aids patients with neuroendocrine tumors SNMMI 2018: A year of promotion and ongoing challenges SNMMI schedules training forum for annual meeting SNMMI offers open access option for JNM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

New theranostic strategy developed for precise tumor diagnosis and therapy
(Society of Nuclear Medicine and Molecular Imaging) A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging. The research was presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective
(Society of Nuclear Medicine and Molecular Imaging) A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors (NETs). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Novel nuclear medicine approach shows promise for treating wide array of cancerous tumors
(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Sanjiv Sam Gambhir, M.D., Ph.D., receives Benedict Cassen Prize for Molecular Imaging Research
(Society of Nuclear Medicine and Molecular Imaging) Sanjiv Sam Gambhir, M.D., Ph.D., known for his pioneering work in multimodality molecular imaging, was awarded the Benedict Cassen Prize during the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Philadelphia, Pa. This honor is awarded every two years by the Education and Research Foundation for Nuclear Medicine and Molecular Imaging in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

New nuclear medicine technique could help tackle brain disease
(Society of Nuclear Medicine and Molecular Imaging) A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2018 Category: International Medicine & Public Health Source Type: news

Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
(Society of Nuclear Medicine and Molecular Imaging) New nuclear medicine tracers could help medical researchers find a cure for Alzheimer's and other neurodegenerative diseases. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2018 Category: International Medicine & Public Health Source Type: news

Combining targeted radionuclide therapy and immunotherapy could improve melanoma survival
(Society of Nuclear Medicine and Molecular Imaging) Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows that combining targeted radionuclide therapy with immunotherapy could improve the survival of patients with metastatic melanoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2018 Category: Cancer & Oncology Source Type: news

Richard L. Wahl, M.D., receives SNMMI 2018 Georg Charles de Hevesy Nuclear Pioneer Award
(Society of Nuclear Medicine and Molecular Imaging) Richard L. Wahl, M.D., FACNM, FACR, received this year's Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to nuclear medicine at the Society of Nuclear Medicine and Molecular Imaging's 2018 Annual Meeting, June 23-26 in Philadelphia. Wahl is the Elizabeth E. Mallinckrodt Professor and head of radiology at Washington University School of Medicine in St. Louis, director of the university's Mallinckrodt Institute of Radiology and a professor of radiation oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2018 Category: Cancer & Oncology Source Type: news

Simon Cherry, Ph.D., receives SNMMI 2018 Paul C. Aebersold Award in Nuclear Medicine Science
(Society of Nuclear Medicine and Molecular Imaging) Simon R. Cherry, Ph.D., Distinguished Professor at the University of California, Davis, has been named the 2018 recipient of the prestigious Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science. Cherry was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2018 Category: Cancer & Oncology Source Type: news

Novel PET tracer successfully images cardiovascular infections
(Society of Nuclear Medicine and Molecular Imaging) A novel positron emission tomography (PET) tracer has been developed that can accurately image cardiovascular infections, which are extremely dangerous and have a high fatality rate. The research was presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2018 Category: Infectious Diseases Source Type: news

Improved PSMA-targeting agent more effective for prostate cancer diagnosis/therapy in mice
(Society of Nuclear Medicine and Molecular Imaging) Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates a potentially more effective method of imaging and treating prostate cancer that modifies a prostate-specific membrane antigen (PSMA)-targeted radioligand by adding an albumin-binding Evans blue (an azo dye) derivative. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2018 Category: Cancer & Oncology Source Type: news

SNMMI 2018: A year of promotion and ongoing challenges
The upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual...Read more on AuntMinnie.comRelated Reading: CMS again declines coverage for NaF-PET scans SNMMI schedules training forum for annual meeting SNMMI seeks to boost molecular imaging's value SNMMI asks Aetna to reconsider PET tracer policy SNMMI taps new slate of officers for 2017-2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2018 Category: Radiology Source Type: news

AAA announces first patients dosed in 2 clinical studies with PSMA-R2 for prostate cancer
(Advanced Accelerator Applications) Advanced Accelerator Applications S.A. (AAA), a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen (PSMA), which is commonly expressed on prostate cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2018 Category: Cancer & Oncology Source Type: news

Novel procedure developed to detect neuroendocrine tumours
Researchers have developed a safer, more effective nuclear medicine method to detect neuroendocrine tumours, according to a new study inThe Journal of Nuclear Medicine.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 7, 2018 Category: Endocrinology Source Type: news

New nuclear medicine method shows promise for better detection of neuroendocrine tumors
(Society of Nuclear Medicine and Molecular Imaging) Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods. The study is featured in the June issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 6, 2018 Category: Cancer & Oncology Source Type: news

SNMMI 2018 Annual Meeting: Imaging the future of human health
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging's 2018 Annual Meeting -- the premier educational, scientific and networking event for the nuclear medicine and molecular imaging community -- will be held at the Pennsylvania Convention Center in Philadelphia, PA, June 23-26. It will bring together physicians, technologists, pharmacists and scientists from around the globe to share research, network, and collaborate on 'Imaging the Future of Human Health.' (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 31, 2018 Category: Cancer & Oncology Source Type: news

SNMMI schedules training forum for annual meeting
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) will host a special...Read more on AuntMinnie.comRelated Reading: SNMMI offers open access option for JNM SNMMI seeks to boost molecular imaging's value SNMMI asks Aetna to reconsider PET tracer policy SNMMI offers patient video on DaT SPECT exams SNMMI urges CMS to classify radiotracers as drugs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 24, 2018 Category: Radiology Source Type: news

SNMMI offers open access option for JNM
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has made available...Read more on AuntMinnie.comRelated Reading: SNMMI seeks to boost molecular imaging's value SNMMI asks Aetna to reconsider PET tracer policy SNMMI offers patient video on DaT SPECT exams SNMMI urges CMS to classify radiotracers as drugs SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 22, 2018 Category: Radiology Source Type: news

SNMMI seeks to boost molecular imaging's value
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is looking to...Read more on AuntMinnie.comRelated Reading: SNMMI asks Aetna to reconsider PET tracer policy SNMMI offers patient video on DaT SPECT exams SNMMI urges CMS to classify radiotracers as drugs SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET SNMMI to watch for job-related health problems (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 18, 2018 Category: Radiology Source Type: news

SNMMI collaborates with industry to advance nuclear medicine and molecular imaging
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Value Initiative Industry Alliance brings members of the corporate community to the table as key players in building the future of nuclear medicine and molecular imaging and demonstrating to the medical community, regulators, patients and the public their crucial role in delivering the highest quality of care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Curium to market xenon-133 gas in the U.S.
Global nuclear medicine firm Curium has expanded its U.S. offerings to include...Read more on AuntMinnie.comRelated Reading: Can nuclear medicine avoid another Mo-99 shortage? NorthStar's novel generator could relieve U.S. isotope shortages SNMMI urges CMS to classify radiotracers as drugs Curium switches Mo-99 production process to LEU IBA Molecular forms Curium as new radiopharmacy player (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2018 Category: Radiology Source Type: news

Novel theranostic approach for treating pancreatic cancer patients shows promise
(Society of Nuclear Medicine and Molecular Imaging) German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

Can nuclear medicine avoid another Mo-99 shortage?
Major changes are taking place in the intricate network that supplies healthcare...Read more on AuntMinnie.comRelated Reading: Canada's NRU reactor to go offline for the final time NorthStar's novel generator could relieve U.S. isotope shortages South African facility resumes Mo-99 production Curium switches Mo-99 production process to LEU SNMMI pushes Congress for U.S.-based Mo-99 supply (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2018 Category: Radiology Source Type: news

SNMMI asks Aetna to reconsider PET tracer policy
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has asked Aetna...Read more on AuntMinnie.comRelated Reading: SNMMI offers patient video on DaT SPECT exams SNMMI urges CMS to classify radiotracers as drugs SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET SNMMI to watch for job-related health problems SNMMI posts criteria for somatostatin receptor PET (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 24, 2018 Category: Radiology Source Type: news

Medical News Today: What are phleboliths and are they safe?
Phleboliths are small, round lumps of calcium that form inside a person's veins. This type of vascular calcification often occurs in the pelvic area and is more common with age. Phleboliths frequently develop in people over 40. On an X-ray, the lumps may be mistaken for kidney stones. Learn more about phleboliths here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 23, 2018 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

SNMMI offers patient video on DaT SPECT exams
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has posted a...Read more on AuntMinnie.comRelated Reading: SNMMI urges CMS to classify radiotracers as drugs SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET SNMMI to watch for job-related health problems SNMMI posts criteria for somatostatin receptor PET SNM issues new guidelines for DaT SPECT imaging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 19, 2018 Category: Radiology Source Type: news

Has standardized testing ruined radiology's board exam?
The radiology board certification exam's shift from an oral exam to a standardized...Read more on AuntMinnie.comRelated Reading: ABR to eliminate 10-year MOC recertification exam ABNM, ABR scrap plan to revamp nuclear medicine training Proposal would dissolve ABNM, fold functions into ABR New core exam: From 'board frenzy' to 'future neglect'? Residents at odds with ABR regarding protected study time (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2018 Category: Radiology Source Type: news

Sonographers exposed to radiation from MPI patients
A new study found that sonographers who performed cardiac ultrasound studies...Read more on AuntMinnie.comRelated Reading: SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET SNMMI to watch for job-related health problems Nuclear medicine techs have higher risk of cataracts CZT-based SPECT MPI may predict cardiac outcomes Cardiac cath radiation exacts toll on health personnel (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2018 Category: Radiology Source Type: news

Study: PET imaging agent could help predict depression drug ’ s efficacy
Image courtesy of Mala Ananth Researchers have identified a positron emission tomography imaging agent that could identify the patients that are more likely to benefit from a drug designed to treat major depressive disorder, according to a study published this month in The Journal of Nuclear Medicine. The C-DASB tracer targets a protein, 5-HTT, found in the part of a person’s brain that is responsible for emotional processing, called the amygdala. Escitalopram, a selective serotonin reuptake inhibitor, is indicated for people with depression, but it doesn’t work for all patients. Scanning a person’s ...
Source: Mass Device - April 6, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Imaging Neurological Pharmaceuticals Research & Development National Institutes of Health (NIH) Source Type: news

PET tracer could help predict treatment effectiveness for depression
(Society of Nuclear Medicine and Molecular Imaging) A positron emission tomography (PET) imaging agent could show, ahead of time, whether a specific treatment is likely to be effective for major depressive disorder (MDD) -- a debilitating condition that affects more than 14 million Americans. No such marker is currently available in clinical psychiatry. The study is featured in the April issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2018 Category: International Medicine & Public Health Source Type: news